Naringin-Based Osteogenic Mechanisms in Bone Health

Naringin, a flavanone glycoside abundant in citrus fruits and traditional herbal preparations, has emerged as a multifunctional agent in bone biology. Its osteogenic effects derive from a combination of pro-osteoblastic and anti-osteoclastic actions, coupled with anti-inflammatory and antioxidant properties. At the cellular level, naringin promotes the proliferation and differentiation of mesenchymal stem cells and osteoprogenitors, upregulating key transcription factors and bone matrix proteins. Mechanistically, it engages several interconnected signalling cascades—among them the BMP-2/Runx2 axis, Wnt/β-catenin stabilisation, Notch activation and VEGF-mediated angiogenesis—to accelerate mineralisation and matrix maturation. Concurrently, naringin inhibits osteoclastogenesis through modulation of RANKL/osteoprotegerin balance and semaphorin-3A‐driven suppression of resorptive activity. These combined pathways culminate in improved bone mineral density, trabecular architecture and biomechanical strength across models of postmenopausal, disuse and diabetic osteoporosis. Translationally, naringin’s low toxicity profile and pleiotropic effects position it as a promising candidate for dietary supplementation, adjuvant therapy in osteoporosis and incorporation into bone tissue engineering constructs.

Research from Nature Portfolio

Recent studies have detailed naringin’s capacity to counteract bone loss under conditions of mechanical unloading. In a denervation‐induced disuse osteoporosis model, administration of naringin restored bone mineral density and trabecular microarchitecture by elevating semaphorin-3A expression and reactivating Wnt/β-catenin signalling. Histological and biochemical analyses confirmed increased osteocalcin labelling and reduced resorption markers, demonstrating a balanced shift towards bone formation. In parallel, combined treatment with naringin and controlled mechanical loading via treadmill exercise in ovariectomised rats yielded additive benefits: bone volume fraction, trabecular number and thickness were maximised and mechanical strength surpassed that of either intervention alone. This combinatorial approach also normalised serum C-terminal telopeptide and enhanced osteocalcin expression, underscoring the synergy between bioactive flavonoids and physiotherapy in restoring skeletal integrity.

Naringin-Based Osteogenic Mechanisms in Bone Health publication trend

The graph below shows the total number of articles in naringin-based osteogenic mechanisms in bone health across all publications each year (not limited to Nature Index journals).

Technical terms

Osteogenic differentiation: Process by which progenitor cells become bone-forming osteoblasts, marked by expression of Runx2 and alkaline phosphatase activity.

Mesenchymal stem cells (MSCs): Multipotent stromal cells capable of differentiating into osteoblasts, chondrocytes and adipocytes under specific cues.

Wnt/β-catenin signalling: Pathway that stabilises β-catenin in the cytoplasm, promoting transcription of osteogenic genes and inhibiting adipogenesis.

BMP-2/Runx2 axis: Osteoinductive cascade where bone morphogenetic protein-2 activates the transcription factor Runx2, essential for early osteoblast commitment.

Notch signalling: Cell–cell communication mechanism that influences osteoprogenitor proliferation and differentiation via Notch receptor cleavage and target gene activation.

Semaphorin-3A: Secreted guidance protein that modulates bone remodelling by promoting osteoblast activity and inhibiting osteoclast formation through Wnt pathway interactions.

Osteoprotegerin (OPG): Decoy receptor for RANKL, preventing osteoclast differentiation and reducing bone resorption.

References

1. The Development of Naringin for Use against Bone and Cartilage Disorders. Molecules (2023).
2. Effects of Naringin on Proliferation and Osteogenic Differentiation of Human Periodontal Ligament Stem Cells In Vitro and In Vivo. Stem Cells International (2015).
3. Naringin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Cells via Activation of the Notch Signaling Pathway. Stem Cells International (2016).
4. Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone. Scientific Reports (2016).
5. The Effects of Combined Treatment with Naringin and Treadmill Exercise on Osteoporosis in Ovariectomized Rats. Scientific Reports (2015).
6. The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts. Evidence-based Complementary and Alternative Medicine (2016).